PP100—Potential of nattokinase as an antithrombotic & fibrinolytic agent
Shirole, T., Sharma, S.L., Jagtap, A.G.
openaire +1 more source
Precise modulation of protein refolding by rationally designed covalent organic frameworks. [PDF]
Guo J +8 more
europepmc +1 more source
Modification of the active centre of nattokinase to enhance its thermostability using a strategy based on molecular dynamics simulation, steered dynamics simulation, and conservative prediction. [PDF]
Li Y +9 more
europepmc +1 more source
Editorial: Plant molecular farming for biopharmaceutical production and beyond. [PDF]
Wang KY, Guo Y.
europepmc +1 more source
Effect of Nattokinase in D-galactose- and Aluminum Chloride-induced Alzheimer's Disease Model of Rat. [PDF]
Tanikawa T +5 more
europepmc +1 more source
Process optimization and evaluation of quality properties of natto with co-culture of Bacillus subtilis natto and Limosilactobacillus fermentum. [PDF]
Ma YN +5 more
europepmc +1 more source
Nanotechnology-based targeted delivery strategies for the treatment of Alzheimer's disease. [PDF]
Yuan X, Tang Q, Wang T.
europepmc +1 more source
X-ray structure determination and deuteration of nattokinase.
Nattokinase (NK) is a strong fibrinolytic enzyme, which is produced in abundance by Bacillus subtilis natto. Although NK is a member of the subtilisin family, it displays different substrate specificity when compared with other subtilisins. The results of molecular simulations predict that hydrogen arrangements around Ser221 at the active site probably
openaire
Vaxtherapy, a Multiphase Therapeutic Protocol Approach for Longvax, the COVID-19 Vaccine-Induced Disease: Spike Persistence as the Core Culprit and Its Downstream Effects. [PDF]
Crespo-Barrios J.
europepmc +1 more source
Production and Purification of Nattokinase from B. Subtilis
openaire +1 more source

